A growing number of companies are offering canine DNA tests for breed identification, genetic disease mutations, and traits.
Results from a randomized clinical trial known as GIFT suggest that genotype-guided warfarin dosing is linked to fewer adverse events than clinical dosing.
An international team of researchers said their set of 80 SNPs could be used to uniquely identify and track personal genome samples.
Earlier this week, the company launched Genomic Explorer in the US, a web-based service that enables consumers to upload their genomic data for viewing and analysis.
The Australian molecular diagnostics firm received 265 test samples during the quarter, including 140 tests issued to Ohio State University as part of an agreement.
Researchers identified truncating, psychosis-related mutations in RBM12 in a family affected by schizophrenia or other psychosis disorders.
Suspicious variants were uncovered through analyses of pediatric cancer survivors from the St. Jude Lifetime Cohort Study and Childhood Cancer Survivor Study.
The team performed a gene expression analysis to discover the new loci, bringing the total number of known risk loci associated with CAD to 73.
Researchers applied a SNP heritability model called LDAK to genetic data for a range of human traits, uncovering relatively high levels of variance explained by SNPs.
Using genome-wide gene association analyses, researchers saw intelligence-related genes and loci overlapping with those in conditions such as schizophrenia.
The New York Times reports that as China invests in science, it also is dealing with research fraud.
In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.
The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.
Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.